Answers are grounded in this paper and cite their sources.
A large proportion of patients with advanced hepatocellular carcinoma (HCC) lack effective therapy. Due to chemoresistance, hope has focused on other approaches including targeted therapies, immune stimulants, and the emerging area of gene therapy. Increasing efforts in basic and clinical development of these approaches will hopefully result in more efficient therapies against HCC.
No takes yet. Share an insight, caveat, or question.
Sangro et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: